Samsung Biologics Co.,Ltd. (KRX: 207940)
South Korea
· Delayed Price · Currency is KRW 949,000
+15,000 (1.61%)
Dec 30, 2024, 3:30 PM KST
Samsung Biologics Co.,Ltd. Market Cap
Samsung Biologics Co.,Ltd. has a market cap or net worth of 66.90 trillion as of January 3, 2025. Its market cap has increased by 31.47% in one year.
Market Cap
66.90T
Enterprise Value
66.89T
Revenue
4.36T
Ranking
n/a
PE Ratio
63.57
Stock Price
949,000.00
Market Cap Chart
Since November 10, 2016, Samsung Biologics Co.,Ltd.'s market cap has increased from 9.53T to 66.90T, an increase of 602.20%. That is a compound annual growth rate of 27.01%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celltrion | 40.59T |
| Yuhan | 8,857.75B |
| SK Biopharmaceuticals | 8,504.82B |
| SK bioscience Co.,Ltd. | 3,948.70B |
| Hanmi Pharm. | 3,531.44B |
| Hanmi Science | 1,977.24B |
| GC Biopharma | 1,967.63B |
| Hanall Biopharma | 1,952.35B |